Neuronal signaling : Oxidants & Alzheimers disease
神经信号传导:氧化剂
基本信息
- 批准号:7259359
- 负责人:
- 金额:$ 22.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-07-01 至 2009-06-30
- 项目状态:已结题
- 来源:
- 关键词:AftercareAgeAlzheimer&aposs DiseaseApoptosisApoptoticAttenuatedBindingCREB1 geneCaspaseCaspase InhibitorCategoriesCell Cycle ArrestCell DeathCell NucleusCellsCessation of lifeConditionCyclic AMP-Responsive DNA-Binding ProteinDNADNA DamageDevelopmentEnzymesFamilyFamily memberFigs - dietaryG-Protein-Coupled ReceptorsGTP-Binding ProteinsGTPase-Activating ProteinsGene ExpressionGlycogen (Starch) SynthaseGlycogen Synthase KinasesGoalsHeterotrimeric GTP-Binding ProteinsImpairmentLeadLinkLipidsMeasurementMediatingMessenger RNAMolecularMonomeric GTP-Binding ProteinsMuscarinic Acetylcholine ReceptorMuscarinicsNerve DegenerationNeurodegenerative DisordersNeuronal DysfunctionNeuronsNuclearNuclear ProteinNuclear ProteinsNumbersOxidantsOxidative StressParkinson DiseasePhosphatidylinositolsPhosphorylationPhosphotransferasesPrevalenceProductionProtein p53ProteinsReactive Oxygen SpeciesReceptor ActivationReportingRoleSecond Messenger SystemsSignal PathwaySignal TransductionSiteStressStrokeSystemTP53 geneTestingTimebasecaspase-3follow-uphuman RGS2 proteininsightloss of functionmemberneuron lossneuronal survivalnovelnovel strategiesprotective effectreceptorreceptor couplingresponserhotranscription factor
项目摘要
DESCRIPTION (provided by applicant): Oxidative stress may be the single most prevalent cause of neuronal dysfunction in neurodegenerative disorders, and its prevalence underscores the need to clarify mechanisms causing and attenuating the deleterious effects, the overall goals of this project. We report exciting and novel results: (1) DNA damaging agents that elevate p53 cause a novel mechanism of activation of the pro-apoptotic glycogen synthase kinase-3b (GSK3b). (2) Oxidative stress induces RGS2 (Regulator of G-protein Signaling 2) expression, a G-protein GTPase-activating protein, providing a mechanistic basis for impaired signaling. (3) Stimulation of muscarinic receptors greatly attenuates oxidative stress-induced apoptosis, remarkably as effectively as a general caspase inhibitor. These results provide important new insights about mechanisms that contribute to oxidative stress-induced impairments and about mechanisms capable of attenuating the deleterious effects. Specific Aim 1 will test the hypothesis that oxidative stress and DNA damage activate p53-mediated signaling encompassing recruitment of GSK3b by a novel activation mechanism. We will test the hypotheses that p53-induced activation of GSK3b leads to inhibition of survival-promoting transcription factor substrates of GSK3b, and promotes responses to p53, identify the p53-binding domain on GSK3b, determine if p53 binding alters the association of GSK3b with other proteins, identify the GSK3b-binding domain on p53 and determine if GSK3b binding alters p53 functions. Specific Aim 2 will test the hypothesis that oxidative stress and DNA damage induce the expression of RGS2 which attenuates muscarinic receptor-coupled signaling and facilitates oxidative stress-induced apoptosis. We will identify the signal mediating H202-induced increases in RGS2, Determine if H202-induced increases in RGS2 impair muscarinic receptor-coupled signaling, and test if IGS2 expression is pro-apoptotic role after oxidative stress. Specific Aim 3 will test the hypothesis that stimulated muscarinic receptors protect cells from oxidative stress, identify the blocked site in -1202-inducedsignaling, test the hypothesis that muscarinic receptors provide protection from other apoptotic conditions, identify the signaling pathways activated by muscarinic receptors providing protection, and test the hypothesis that activation of Rho family small G-proteins is protective.
描述(由申请人提供):氧化应激可能是神经退行性疾病中神经元功能障碍的最普遍原因,其普遍性强调需要澄清导致和减弱有害影响的机制,这是该项目的总体目标。我们报告了令人兴奋的新颖结果:(1) 升高 p53 的 DNA 损伤剂导致促凋亡糖原合成酶激酶 3b (GSK3b) 的激活的新机制。 (2) 氧化应激诱导 RGS2(G 蛋白信号传导调节器 2)表达,这是一种 G 蛋白 GTP 酶激活蛋白,为信号传导受损提供机制基础。 (3) 刺激毒蕈碱受体可极大地减弱氧化应激诱导的细胞凋亡,其效果与一般的 caspase 抑制剂相当。这些结果提供了关于导致氧化应激引起的损伤的机制以及能够减轻有害影响的机制的重要新见解。具体目标 1 将检验氧化应激和 DNA 损伤激活 p53 介导的信号传导(包括通过一种新的激活机制招募 GSK3b)的假设。我们将测试以下假设:p53 诱导的 GSK3b 激活会抑制 GSK3b 的生存促进转录因子底物,并促进对 p53 的反应,识别 GSK3b 上的 p53 结合结构域,确定 p53 结合是否会改变 GSK3b 与其他蛋白质,识别 p53 上的 GSK3b 结合域并确定 GSK3b 结合是否会改变 p53 功能。具体目标 2 将检验氧化应激和 DNA 损伤诱导 RGS2 表达的假设,RGS2 会减弱毒蕈碱受体偶联信号传导并促进氧化应激诱导的细胞凋亡。我们将鉴定介导 H2O2 诱导的 RGS2 增加的信号,确定 H2O2 诱导的 RGS2 增加是否损害毒蕈碱受体偶联信号传导,并测试 IGS2 表达在氧化应激后是否具有促凋亡作用。具体目标 3 将检验受刺激的毒蕈碱受体可保护细胞免受氧化应激的假设,识别 -1202 诱导信号传导中的阻断位点,检验毒蕈碱受体提供保护免受其他凋亡情况的假设,识别由提供保护的毒蕈碱受体激活的信号传导途径,并检验 Rho 家族小 G 蛋白的激活具有保护作用的假设。
项目成果
期刊论文数量(31)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity.
- DOI:10.1016/j.cellsig.2008.10.014
- 发表时间:2009-02
- 期刊:
- 影响因子:4.8
- 作者:Yuskaitis CJ;Jope RS
- 通讯作者:Jope RS
Nuclear accumulation of glycogen synthase kinase-3 during replicative senescence of human fibroblasts.
人成纤维细胞复制衰老过程中糖原合成酶激酶 3 的核积累。
- DOI:10.1111/j.1474-9728.2004.00117.x
- 发表时间:2004
- 期刊:
- 影响因子:7.8
- 作者:Zmijewski,JaroslawW;Jope,RichardS
- 通讯作者:Jope,RichardS
Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain.
- DOI:10.1186/1742-2094-6-9
- 发表时间:2009-03-11
- 期刊:
- 影响因子:9.3
- 作者:Beurel E;Jope RS
- 通讯作者:Jope RS
Second messengers regulate RGS2 expression which is targeted to the nucleus.
第二信使调节针对细胞核的 RGS2 表达。
- DOI:10.1016/s0167-4889(01)00144-6
- 发表时间:2001
- 期刊:
- 影响因子:0
- 作者:Zmijewski,JW;Song,L;Harkins,L;Cobbs,CS;Jope,RS
- 通讯作者:Jope,RS
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD S. JOPE其他文献
RICHARD S. JOPE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD S. JOPE', 18)}}的其他基金
Inflammatory signaling in depression regulated by Toll-like receptors 2 and 4
Toll 样受体 2 和 4 调节抑郁症中的炎症信号传导
- 批准号:
10083684 - 财政年份:2018
- 资助金额:
$ 22.86万 - 项目类别:
IMPAIRED SIGNAL TRANSDUCTION BY ALZHEIMERS DISEASE AND GLUCOCORTICOIDS
阿尔茨海默病和糖皮质激素导致的信号传导受损
- 批准号:
6334857 - 财政年份:2000
- 资助金额:
$ 22.86万 - 项目类别:
NEURONAL SIGNALING--OXIDANTS AND ALZHEIMERS DISEASE
神经信号传导——氧化剂和阿尔茨海默病
- 批准号:
6393968 - 财政年份:1999
- 资助金额:
$ 22.86万 - 项目类别:
相似国自然基金
HTRA1介导CTRP5调控脂代谢通路在年龄相关性黄斑变性中的致病机制研究
- 批准号:82301231
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PLAAT3降低介导线粒体降解异常在年龄相关性白内障发病中的作用及机制
- 批准号:82301190
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
跨尺度年龄自适应儿童头部模型构建与弥漫性轴索损伤行为及表征研究
- 批准号:52375281
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
ALKBH5通过SHP-1调控视网膜色素上皮细胞铁死亡在年龄相关性黄斑变性中的作用机制研究
- 批准号:82301213
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
叶黄素调控脂代谢紊乱所致年龄相关性黄斑病变的血-视网膜屏障损伤机制研究
- 批准号:82373570
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
MIND Foods and Aerobic Training in Black Adults with HTN: An ADRD Prevention Pilot RCT (MAT)
MIND 食品和患有 HTN 的黑人成人的有氧训练:ADRD 预防试点随机对照试验 (MAT)
- 批准号:
10585366 - 财政年份:2023
- 资助金额:
$ 22.86万 - 项目类别:
Reduced Alzheimer's disease progression and neutrophil adhesion via competition using neutrophil-derived or engineered nanoparticles
通过使用中性粒细胞衍生的或工程化的纳米颗粒竞争,减少阿尔茨海默病的进展和中性粒细胞粘附
- 批准号:
10799111 - 财政年份:2023
- 资助金额:
$ 22.86万 - 项目类别:
Extratumoral biological determinants that decrease survival in older adults with glioblastoma
降低老年胶质母细胞瘤患者生存率的肿瘤外生物决定因素
- 批准号:
10741380 - 财政年份:2023
- 资助金额:
$ 22.86万 - 项目类别:
Treatment of OSA on sleep-dependent memory and blood biomarkers in blacks
OSA 治疗对黑人睡眠依赖性记忆和血液生物标志物的影响
- 批准号:
10740142 - 财政年份:2023
- 资助金额:
$ 22.86万 - 项目类别:
Assessment of ultrasound-facilitated neurotherapeutics in Alzheimer's disease
超声辅助神经疗法治疗阿尔茨海默病的评估
- 批准号:
10901036 - 财政年份:2023
- 资助金额:
$ 22.86万 - 项目类别: